Addiction News and Research

RSS

Blocking BRAF ubiquitination may be an effective treatment approach in melanoma

The protein BRAF is a key player in the development of many different types of cancer, including melanoma.

24 Apr 2019

Amid opioid prescriber crackdown, health officials reach out to pain patients

A pharmacist in Celina, Tenn., was one of 60 people indicted on charges of opioid-related crimes last week, in a multistate sting. John Polston was charged with 21 counts of filling medically unnecessary narcotic prescriptions.

24 Apr 2019

Cochrane Review looks at different ways to use nicotine replacement therapies

New evidence published in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.

24 Apr 2019

Traditional and e-cigarette users may be more receptive to smoking cessation interventions

A study by MassGeneral Hospital for Children researchers finds that parents who use both traditional cigarettes and e-cigarettes may be more receptive to smoking cessation interventions than parents who only smoke traditional cigarettes.

23 Apr 2019

Neuroscientists propose new theory about amyloid precursor protein connection in Alzheimer's

Worldwide, 50 million people are living with Alzheimer's disease and other dementias. According to the Alzheimer's Association, every 65 seconds someone in the United States develops this disease, which causes problems with memory, thinking and behavior.

23 Apr 2019

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.

22 Apr 2019

Oxytocin blocks excess drinking in alcohol-dependent rats

The neuropeptide oxytocin blocks enhanced drinking in alcohol-dependent rats, according to a study published April 16 in the open-access journal PLOS Biology led by Drs. Tunstall, Koob and Vendruscolo of the National Institutes of Health, and Drs. Kirson and Roberto of The Scripps Research Institute.

17 Apr 2019

Universities join hands to confront opioid problem in the central Appalachian region

Go to Google and type: "leading cause of accidental death in ..." Then type in a state -- any state in central Appalachia -- and hit search. The answer is the same: opioid overdoses and drug poisoning lead the way in fatalities in these states, far above former front-runners, such as car accidents and gun violence.

17 Apr 2019

PCORI’s newly approved awards focus on cancer pain and opioid use disorders

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $44.6 million to fund 12 studies comparing the best ways to treat a range of health conditions that impose high burdens on patients, caregivers and the healthcare system.

17 Apr 2019

Research shows mindful body awareness training helps women recover from drug addiction

A novel type of body awareness training helps women recover from drug addiction, according to new research from the University of Washington. People in the study made marked improvement, and many improvements lasted for a year.

17 Apr 2019

Neuronal mechanisms underlying formation and retrieval of cocaine-associated memories

The environmental context in which addicts experience the rewarding effects of cocaine can readily elicit cocaine-associated memories. These memories persist long after abstinence and trigger cocaine-craving and consumption.

15 Apr 2019

New series offers global evidence detailing role of surgery in the opioids crisis

Targets to eliminate pain after surgery have driven increases in the use of opioids, and are a major cause of the opioid crisis in the USA, Canada and other countries.

12 Apr 2019

Cancer patients and those with anemia should not be denied opioids, says CDC

The U.S. CDC has issued a letter clarifying that people suffering from severe pain caused by cancer or sickle-cell anemia should not be denied prescriptions for opioid pain-killers.

11 Apr 2019

Penn State-led project focuses on opioid addiction treatment in teens

Substance use disorders continue to rise at alarming rates among adolescents, with opioid abuse contributing to this significant public health problem.

10 Apr 2019

Study of OUD treatment creates new metric to illustrate disadvantaged areas in the U.S.

Ohio, West Virginia, and the District of Columbia have the highest disparity between opioid-related deaths and access to treatment providers for opioid use disorder in the U.S.

10 Apr 2019

Bringing Maine researchers together to identify solutions to opioid epidemic in Maine

The MDI Biological Laboratory and the University of New England are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in Maine.

10 Apr 2019

Prescribed medication reduces arrests, incarceration among people with opioid use disorder

When it comes to addressing the national opioid crisis, most of the research has focused on the physical health risks faced by people with opioid use disorder, such as overdose and infectious disease.

9 Apr 2019

Graphic anti-smoking warning labels on cigarette packs may deter some sales

Placing graphic anti-smoking warning labels on cigarette packages may deter some adults from purchasing tobacco products, but the strategy is unlikely to influence those smokers who are most addicted to nicotine, according to a new RAND Corporation study.

9 Apr 2019

Dedicated intervention can double smoking quit rates for people with severe mental illness

Research published in the Lancet Psychiatry has found a dedicated intervention to help people with severe mental illness stop smoking can double quit rates at six months compared to standard care.

9 Apr 2019

Advances in deep brain stimulation for Parkinson’s could lead to treatments for other disorders

A new paper published in Nature Reviews Neurology suggests that recent advances in deep brain stimulation for Parkinson disease could lead to treatments for conditions such as obsessive-compulsive disorder, Gilles de la Tourette syndrome and depression.

8 Apr 2019

Addiction News and Research

Blocking BRAF ubiquitination may be an effective treatment approach in melanoma

Amid opioid prescriber crackdown, health officials reach out to pain patients

Cochrane Review looks at different ways to use nicotine replacement therapies

Traditional and e-cigarette users may be more receptive to smoking cessation interventions

Neuroscientists propose new theory about amyloid precursor protein connection in Alzheimer's

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

Oxytocin blocks excess drinking in alcohol-dependent rats

Universities join hands to confront opioid problem in the central Appalachian region

PCORI’s newly approved awards focus on cancer pain and opioid use disorders

Research shows mindful body awareness training helps women recover from drug addiction

Neuronal mechanisms underlying formation and retrieval of cocaine-associated memories

New series offers global evidence detailing role of surgery in the opioids crisis

Cancer patients and those with anemia should not be denied opioids, says CDC

Penn State-led project focuses on opioid addiction treatment in teens

Study of OUD treatment creates new metric to illustrate disadvantaged areas in the U.S.

Bringing Maine researchers together to identify solutions to opioid epidemic in Maine

Prescribed medication reduces arrests, incarceration among people with opioid use disorder

Graphic anti-smoking warning labels on cigarette packs may deter some sales

Dedicated intervention can double smoking quit rates for people with severe mental illness

Advances in deep brain stimulation for Parkinson’s could lead to treatments for other disorders

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News